Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of NanaBis for metastatic bone pain in cancer
ACTRN12621001302842Phase 3Not yet recruiting
- Sponsor
- Medlab Clinical
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of NanaBis in cancer pain and ostealgia (3 arms), sponsored by Medlab Clinical. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
NanaBis
03
Conditions
cancer painostealgia
Beyond the preview
Go deeper on ACTRN12621001302842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001302842.